Related Experiment Video

Updated: Jul 15, 2026

Rearing the Cabbage White Butterfly (Pieris rapae) in Controlled Conditions: A Case Study with Heavy Metal Tolerance
08:08

Rearing the Cabbage White Butterfly (Pieris rapae) in Controlled Conditions: A Case Study with Heavy Metal Tolerance

Published on: August 18, 2023

Update on the clinical management of childhood lead poisoning

Alan D Woolf1, Rose Goldman, David C Bellinger

  • 1Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. alan.woolf@childrens.harvard.edu

Pediatric Clinics of North America
|April 24, 2007
PubMed

Insights

Childhood lead poisoning remains a significant public health concern, with new evidence linking even low blood lead levels to potential neurologic injury in children. This review covers risk factors, sources, pathophysiology, and management strategies for lead poisoning.

Area of Science:

  • Environmental Health
  • Pediatrics
  • Toxicology

Background:

  • Childhood lead poisoning is a persistent public health problem in the U.S.
  • Affects thousands of children and their families annually.
  • Emerging research indicates neurologic injury risk even at low blood lead levels (<10 microg/dL).

Purpose of the Study:

  • To review current knowledge on childhood lead poisoning.
  • To highlight high-risk populations and novel contamination sources.
  • To discuss updated pathophysiology, clinical management, and prevention.

Main Methods:

  • Literature review of recent studies and clinical guidelines.
  • Synthesis of evidence on lead exposure and health effects.
  • Analysis of risk factors, unusual sources, and pathophysiology.

Main Results:

  • Low blood lead levels (<10 microg/dL) are associated with neurologic injury.
  • Identifies specific characteristics of children at high risk.
  • Explores less common sources of lead contamination.

Conclusions:

  • Childhood lead poisoning requires ongoing attention and updated management strategies.
  • Early identification and prevention are crucial for mitigating long-term health effects.
  • Further research into lead's pathophysiology and novel interventions is warranted.

Related Concept Videos

Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...